...
首页> 外文期刊>International Medical Case Reports Journal >Combined Central Retinal Vein And Artery Occlusion In A Patient With Elevated Level Of Factor VIII: A Case Report
【24h】

Combined Central Retinal Vein And Artery Occlusion In A Patient With Elevated Level Of Factor VIII: A Case Report

机译:VIII因子水平升高的患者合并中央视网膜静脉和动脉闭塞:一例报告

获取原文

摘要

Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) with central retinal artery occlusion (CRAO) in a patient with elevated Factor VIII. Case presentation: A 48-year-old woman presented with a complaint of decreased visual acuity in her left eye that began 6 weeks prior. The patient had diabetes. The best-corrected visual acuity (BCVA) was hand motion, IOP was 34 mmHg, and there was a neovascularization of the iris in the left eye. A complete fundus evaluation including fluorescein angiography showed non-proliferative diabetic retinopathy in the right eye and CRVO with CRAO in the left eye. Systemic evaluation revealed elevated fibrinogen and Factor VIII suggestive of the diagnosis of thrombophilia due to elevated Factor VIII. This symptom was the first sign of the underlying disorder. IOP was normalized 1 week after IOP lowering agents were applied. Intravitreal anti-vascular endothelial growth factor treatment and pan-retinal photocoagulation were performed in the left eye. Additionally, to treat thrombophilia, warfarin treatment was started and flame-shaped retinal hemorrhage with cotton wool patch near the optic disc and around the retinal vascular arcade at the posterior pole had occurred in the right eye during treatment. Then, warfarin treatment was discontinued and retinal hemorrhage was decreased. In the left eye, the BCVA did not change during treatment. Conclusion: Elevated levels of Factor VIII as an independent risk in the development of venous thromboembolism. Combined cases usually present with severe visual loss and such patients should be thoroughly evaluated to diagnose underlying factors including Factor VIII, and initiate appropriate management at the earliest.
机译:目的:报道一例VIII因子升高的患者单侧视网膜中央静脉阻塞(CRVO)合并视网膜中央动脉阻塞(CRAO)的病例。病例介绍:一名48岁妇女因左眼视敏度下降而抱怨,该症状始于6周前。该患者患有糖尿病。最佳矫正视力(BCVA)是手部动作,IOP为34 mmHg,左眼虹膜有新血管形成。包括荧光素血管造影在内的完整眼底评估显示右眼为非增生性糖尿病性视网膜病变,左眼为CRVO和CRAO。系统评价显示纤维蛋白原和因子VIII升高,提示因因子VIII升高引起的血栓形成诊断。这种症状是潜在疾病的第一个迹象。应用降眼压剂后1周,眼压恢复正常。在左眼进行玻璃体内抗血管内皮生长因子治疗和全视网膜光凝。此外,为了治疗血栓形成,华法林开始治疗,在治疗过程中右眼在视盘附近和后极视网膜血管拱廊周围发生了棉绒补丁引起的火焰状视网膜出血。然后,停止使用华法林治疗,并减少了视网膜出血。在左眼中,治疗期间BCVA没有改变。结论:因子VIII水平升高是静脉血栓栓塞发展的独立风险。合并病例通常伴有严重的视力丧失,应该对这些患者进行彻底评估,以诊断包括因子VIII在内的潜在因素,并尽早开始适当的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号